Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2192)
All Articles published online
|
Feb 14, 2009 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pastor R, Habersetzer F, Fafi-Kremer S, Doffoël M, Baumert TF, Gut JP, Stoll-Keller F, Schvoerer E. Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients. World J Gastroenterol 2009; 15(6): 753-755 [PMID: 19222103 DOI: 10.3748/wjg.15.753] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i6/753.htm |
| Number | Citing Articles |
| 1 |
Alireza Mohebbi, Nazanin Lorestani, Alireza Tahamtan, Niki L. Kargar, Alijan Tabarraei. An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00662
|
| 2 |
Bhupesh Singla, Rajasri Bhattacharyya, Anuradha Chakraborti, Bal Krishan Sharma, Shweta Kapil, Yogesh K. Chawla, Sunil K. Arora, Ashim Das, Radha K. Dhiman, Ajay Duseja. Response to potent anti-HBV agents in chronic hepatitis B and combined effect of HBV reverse transcriptase mutations. Gene 2015; 567(1): 22 doi: 10.1016/j.gene.2015.04.060
|
| 3 |
Rajesh Panigrahi, Avik Biswas, Binay Krishna De, Sekhar Chakrabarti, Runu Chakravarty. Characterization of antiviral resistance mutations among the Eastern Indian Hepatitis B virus infected population. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-56
|
| 4 |
Jiyun Fan, Yaqing Zhang, Hui Xiong, Ying Wang, Xiaokui Guo. Nucleotide analogue-resistant mutations in hepatitis B viral genomes found in hepatitis B patients. Journal of General Virology 2015; 96(3): 663 doi: 10.1099/jgv.0.000010
|
| 5 |
Jules L. Dienstag. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2015; : 563 doi: 10.1016/B978-1-4557-4801-3.00046-1
|
| 6 |
S. Mirandola, D. Campagnolo, G. Bortoletto, L. Franceschini, M. Marcolongo, A. Alberti. Large‐scale survey of naturally occurring HBV polymerase mutations associated with anti‐HBV drug resistance in untreated patients with chronic hepatitis B. Journal of Viral Hepatitis 2011; 18(7) doi: 10.1111/j.1365-2893.2011.01435.x
|
| 7 |
Profile of Mutations in the Reverse Transcriptase and Overlapping Surface Genes of Hepatitis B Virus (HBV) in Treatment-Naïve Indonesian HBV Carriers. Japanese Journal of Infectious Diseases 2017; 70(6): 647 doi: 10.7883/yoken.JJID.2017.078
|
| 8 |
Rebecca T. Horvat. Diagnostic and Clinical Relevance of HBV Mutations. Laboratory Medicine 2011; 42(8): 488 doi: 10.1309/LM7SF4QZMEG5LVPN
|
| 9 |
R. Salpini, V. Svicher, V. Cento, C. Gori, A. Bertoli, F. Scopelliti, V. Micheli, T. Cappiello, A. Spanò, G. Rizzardini, G.M. De Sanctis, C. Sarrecchia, M. Angelico, C.F. Perno. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. Antiviral Research 2011; 92(2): 382 doi: 10.1016/j.antiviral.2011.08.013
|
| 10 |
Avik Biswas, Rajesh Panigrahi, Partha Kumar Chandra, Arup Banerjee, Sibnarayan Datta, Manisha Pal, Subhashish Chakraborty, Prasun Bhattacharya, Sekhar Chakrabarti, Runu Chakravarty. Characterization of the Occult Hepatitis B Virus Variants Circulating among the Blood Donors from Eastern India. The Scientific World Journal 2013; 2013: 1 doi: 10.1155/2013/212704
|
| 11 |
Bo Langhoff Hønge, Sanne Jespersen, Candida Medina, David da Silva Té, Zacarias José da Silva, Sharon Lewin, Lars Østergaard, Christian Erikstrup, Christian Wejse, Alex Lund Laursen, Henrik Krarup, Isabelle A. Chemin. Hepatitis B and Delta Virus Are Prevalent but Often Subclinical Co-Infections among HIV Infected Patients in Guinea-Bissau, West Africa: A Cross-Sectional Study. PLoS ONE 2014; 9(6): e99971 doi: 10.1371/journal.pone.0099971
|
| 12 |
FRED Y. AOKI, FREDERICK G. HAYDEN, RAPHAEL DOLIN. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2010; : 565 doi: 10.1016/B978-0-443-06839-3.00041-2
|
| 13 |
Julien Dupouey, René Gerolami, Caroline Solas, Philippe Colson. Hepatitis B virus variant with the a194t substitution within reverse transcriptase before and under adefovir and tenofovir therapy. Clinics and Research in Hepatology and Gastroenterology 2012; 36(2): e26 doi: 10.1016/j.clinre.2012.01.003
|
| 14 |
R. A. A. Pondé, D. D. P. Cardoso, M. O. Ferro. The underlying mechanisms for the ‘anti-HBc alone’ serological profile. Archives of Virology 2010; 155(2): 149 doi: 10.1007/s00705-009-0559-6
|
| 15 |
Marta Alvarez Estévez, Natalia Chueca-Porcuna, Vicente Guillot-Suay, Alejandro Peña-Monje, Fernando García-García, Federico García-García. Baja prevalencia de resistencias primarias frente al virus de la hepatitis B en el sur de España. Enfermedades Infecciosas y Microbiología Clínica 2013; 31(8): 520 doi: 10.1016/j.eimc.2013.02.014
|
| 16 |
Silvia Mirandola, Giada Sebastiani, Cristina Rossi, Emanuela Velo, Elke Maria Erne, Alessandro Vario, Diego Tempesta, Chiara Romualdi, Davide Campagnolo, Alfredo Alberti. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy. Antiviral Research 2012; 96(3): 422 doi: 10.1016/j.antiviral.2012.09.014
|
| 17 |
Dwayne M. Baxa, Ashish D. Thekdi, Alicia Golembieski, Prashant V. Krishnan, Omar Sharif, Anne Kizy, Lynne Shetron-Rama, John Jovanovich, Brandi J. Chappell, Andrea Snow-Lampart, Katyna Borroto-Esoda, Stuart C. Gordon. Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States. Journal of Hepatology 2013; 58(2): 212 doi: 10.1016/j.jhep.2012.09.014
|
| 18 |
Mutation Profiling of the Hepatitis B Virus Strains Circulating in North Indian Population. PLoS ONE 2014; 9(3): e91150 doi: 10.1371/journal.pone.0091150
|
| 19 |
Neil Rajoriya, Christophe Combet, Fabien Zoulim, Harry L.A. Janssen. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?. Journal of Hepatology 2017; 67(6): 1281 doi: 10.1016/j.jhep.2017.07.011
|
| 20 |
Jing Wang, Jinfeng Liu, Qiang Yu, Li Jin, Naijuan Yao, Yuan Yang, Taotao Yan, Chunhua Hu, Yingli He, Yingren Zhao, Tianyan Chen, Jie Zheng, Louis Detolla. High Prevalence of Preexisting HBV Polymerase Mutations in Pregnant Women Does Not Limit the Antiviral Therapy Efficacy. Canadian Journal of Infectious Diseases and Medical Microbiology 2021; 2021: 1 doi: 10.1155/2021/6653546
|
| 21 |
Jie Chen, Ling Yan, Feng‐Cai Zhu, Jian‐Xun Liu, Rong‐Cheng Li, Fu‐Zhen Wang, Jie Li, Hui Zhuang. Amino acid polymorphism in the reverse transcriptase region of hepatitis B virus and the relationship with nucleos(t)ide analogues treatment for preventing mother‐to‐infant transmission. Journal of Medical Virology 2014; 86(8): 1288 doi: 10.1002/jmv.23948
|
| 22 |
Xiaodong Li, Yan Liu, Pan Zhao, Yan Wang, Li Chen, Shaojie Xin, Xin-Xin Zhang, Dongping Xu. Investigation into Drug-Resistant Mutations of HBV from 845 Nucleoside/Nucleotide Analogue-Naive Chinese Patients with Chronic HBV Infection. Antiviral Therapy 2015; 20(2): 141 doi: 10.3851/IMP2813
|
| 23 |
D. A. Fernández‐Galindo, F. Sánchez‐Ávila, L. Bobadilla‐Morales, P. Gómez‐Quiróz, M. Bueno‐Topete, J. Armendáriz‐Borunda, L. V. Sánchez‐Orozco. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H. Journal of Medical Virology 2015; 87(6): 985 doi: 10.1002/jmv.24098
|
| 24 |
Sema Alacam, Nuran Karabulut, Ayfer Yolcu, Mustafa Onel, Alp Atasoy, Sabahattin Kaymakoglu, Ali Agacfidan. Evaluation of drug resistance mutations in patients with chronic hepatitis B. Folia Microbiologica 2019; 64(2): 237 doi: 10.1007/s12223-018-0650-z
|
| 25 |
Lauren M Hynicka, Nancy Yunker, Punam H Patel. A Review of Oral Antiretroviral Therapy for the Treatment of Chronic Hepatitis B. Annals of Pharmacotherapy 2010; 44(7-8): 1271 doi: 10.1345/aph.1M590
|
| 26 |
Filippo Morando, Silvia Rosi, Silvano Fasolato, Marta Cavallin, Elisabetta Gola, Angelo Gatta, Paolo Angeli. Severe acute hepatitis B in a treatment‐naïve patient with antiviral drug resistant mutations in the polymerase gene. Journal of Medical Virology 2013; 85(2): 210 doi: 10.1002/jmv.23448
|
| 27 |
Elisabete Arrese, Miren Basaras, Sonia Blanco, Pablo Ruiz, Ramόn Cisterna. Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B . Annals of Hepatology 2011; 10(4): 434 doi: 10.1016/S1665-2681(19)31509-1
|
| 28 |
Jing Li, Donghua Zhang, Xinxin Zhang. The Occurrence of rtA194T Mutant After Long-Term Lamivudine Monotherapy Remains Sensitive to Tenofovir Disoproxil Fumarate: A Case Report. Infection and Drug Resistance 2021; : 1013 doi: 10.2147/IDR.S295060
|
| 29 |
Knud Schewe, Christian Noah, Hüseyin Sirma, Stefan Schmiedel, Jan van Lunzen, Jürgen Kurt Rockstroh, Oliver Schildgen. Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report. Viruses 2010; 2(8): 1564 doi: 10.3390/v2081564
|
| 30 |
Modhusudon Shaha, Sheikh Ariful Hoque, Sabita Rezwana Rahman. Molecular epidemiology of hepatitis B virus isolated from Bangladesh. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3174-5
|